Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapy
Scientists at University of Rouen detail research in chemotherapy
March 2nd, 2007
A report, "Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci," is newly published data in Antimicrobial Agents and Chemotherapy. In this recent report published in the journal Antimicrobial Agents and Chemotherapy, researchers in Rouen, France conducted a study "Tolerance to vancomycin and teicoplanin in 90 clinical isolates of coagulase-negative staphylococci (CoNS) was investigated by time-kill curve methodology." "Only six strains, belonging to the Staphylococcus lugdunensis species, exhibited tolerance. The seven other S. lugdunensis strains tested displayed weak susceptibility to the bactericidal activity of...
Source: Drug Week (2007-03-02)
|
